Doxercalciferol
Doxercalciferol | |
---|---|
IUPAC name (1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol | |
Other names 1-Hydroxyergocalciferol; 1-Hydroxyvitamin D2; 1α-Hydroxyergocalciferol; 1α-Hydroxyvitamin D2; Hectorol; TSA 840 | |
Identifiers | |
CAS number | 54573-75-0 |
PubChem | 5281107 |
ChemSpider | 4444554 |
UNII | 3DIZ9LF5Y9 |
ChEMBL | CHEMBL1200810 |
ATC code | H05 |
Jmol-3D images | {{#if:O[C@@H]1CC(\C(=C)[C@@H](O)C1)=C\C=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](/C=C/[C@H](C)C(C)C)C)C|Image 1 |
| |
| |
Properties | |
Molecular formula | C28H44O2 |
Molar mass | 412.65 g mol−1 |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
Infobox references | |
Doxercalciferol (trade name Hectorol) is drug for secondary hyperparathyroidism and metabolic bone disease.[1] It is a synthetic analog of ergocalciferol (vitamin D2). It suppresses parathyroid synthesis and secretion.[2]
References
- ↑ Sprague S M; Ho L T (2002). "Oral doxercalciferol therapy for secondary hyperparathyroidism in a peritoneal dialysis patient". Clinical nephrology 58 (2): 155–160. PMID 12227689.
- ↑ "Doxercalciferol". Drugs.com.
|